Report Detail

Request for Sample of this report

Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Type (Diagnostic, and Screening), Disease Indication (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, Recurrent Pregnancy Loss, Antiphospholipid Syndrome (APL), and Other Diseases), Technology (Spectrophotometer, Polymerase Chain Reaction, Fluorescence In-situ Hybridization, Array Comparative Genomic Hybridization, and Others), End User (Hospitals & Clinics, Diagnostic Cent

RnM3728087
06 September, 2019
Global
154 Pages
The Insight Partners
Biotechnology

Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 – Regional Analysis and Forecasts by Type, Disease Indication, Technology, and End User
The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from 2019-2027.
The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing. On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years. Soaring birth rates among developing economies are responsible for fueling global baby boom. However, the rising birth rate also contributes to rising birth defects and infants suffering from several genetic diseases. According to a report published by Bill and Melinda Gates Foundation in 2018, there are almost 250 babies born every minute around the globe. Moreover, according to the Centers for Disease Control and Prevention, the fertility rates for Hispanic women was highest in 2017 among Hispanic women with 67.1 births per 1,000 women.
Asian countries such as India and China also have high fertility rates due to factors such as effects of religion, inadequate supply of family welfare services, poverty, and others. According to the World Bank in 2016, the fertility rates in India were reported to be 2.23 births per women as compared to 1.80 in the United States and 1.62 in China. Moreover, neighboring countries in India, such as Pakistan also has alarming rates of fertility. In 2016, the birth rate in Pakistan was reported to be 3.48 births per woman as per the World Bank data. However, the birthrate in India have successfully reduced its high fertility rate, but still is high as compared to other developed nations. According to the United Nations (UN) report published on June 2019, the fertility rate has reduced to 2.1. Therefore, by 2050 additional 273 million people will be added to India’s population. The increasing number of parturient women across the world are thus likely to create increasing demand for prenatal and newborn genetic tests across the globe leading to the growth of the market.
The Asia Pacific prenatal and newborn genetic testing market, based on the disease indication was segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria, recurrent pregnancy loss, and Antiphospholipid syndrome, and other diseases. In 2018, Down syndrome segment held the largest share of the market, by disease indication. The highest share of Down syndrome attributes to the high prevalence of this genetic abnormality among fetuses and availability of multiple tests for its screening and diagnostics. However, the cystic fibrosis segment is expected to grow at the fastest rate during the coming year.
Some of the major primary and secondary sources for prenatal and newborn genetic testing included in the report are Food & Drug Administration (FDA), Indian Institutes of Technology (IITs), International Trade Administration (ITA), Japan Society of Obstetrics and Gynecology (JSOG), Council of Scientific and Industrial Research (cSIR), Pakistan Down Syndrome Association (PDSA) and others.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Type
- 1.3.2 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Disease Indication
- 1.3.3 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Technology
- 1.3.4 Asia Pacific Prenatal and Newborn Genetic Testing Market - By End User
- 1.3.5 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Country

2. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Prenatal And Newborn Genetic Testing- Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific - PEST Analysis

5. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Burden of Genetic Diseases in India
- 5.1.2 Increasing Fertility Rate
5.2 Key Market Restraints
- 5.2.1 Risks Associated with Prenatal Testing
5.3 Key Market Opportunities
- 5.3.1 Development of Policy for Treatment of Rare Diseases
5.4 Future Trends
- 5.4.1 Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market
5.5 Impact Analysis

6. Prenatal And Newborn Genetic Testing Market - Asia Pacific Analysis

6.1 Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis
6.2 Performance of Key Players
- 6.2.1 F. Hoffmann La-Roche Ltd.
- 6.2.2 Laboratory Corporation of America Holdings (Sequenom)
- 6.2.3 PerkinElmer, Inc.
6.3 India Ultrasound Screening Market
- 6.3.1 Nuchal Translucency
  - 6.3.1.1 Overview
  - 6.3.1.2 Nuchal Translucency Market Revenue and Forecast to 2027 (US$ Mn)
- 6.3.2 Fetal Nasal Bone
  - 6.3.2.1 Overview
  - 6.3.2.2 Fetal Nasal Bone Market Revenue and Forecast to 2027 (US$ Mn)
- 6.3.3 Tricuspid Regurgitation
  - 6.3.3.1 Overview
  - 6.3.3.2 Tricuspid Regurgitation (TR) Market Revenue and Forecast to 2027 (US$ Mn)
7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Type
- 7.1 Overview
- 7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Type 2018 & 2027 (%)
- 7.3 Diagnostic Market
  - 7.3.1 Overview
  - 7.3.2 Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.3.3 Amniocentesis Market
    - 7.3.3.1 Overview
    - 7.3.3.2 Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.3.4 Chorionic Villus Sampling Market
    - 7.3.4.1 Overview
    - 7.3.4.2 Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.3.5 Cytogenetic and Pharmacogenetic Testing Market
    - 7.3.5.1 Overview
    - 7.3.5.2 Cytogenetic and Pharmacogenetic Testing Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4 Screening Market
  - 7.4.1 Overview
  - 7.4.2 Screening Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.4.3 Maternal Serum Screening Market
    - 7.4.3.1 Overview
    - 7.4.3.2 Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.4.4 Non-Invasive Prenatal Testing Market
    - 7.4.4.1 Overview
    - 7.4.4.2 Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)
  8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Disease Indication
  - 8.1 Overview
  - 8.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Disease Indication 2018 & 2027 (%)
  - 8.3 Cystic Fibrosis
    - 8.3.1 Overview
    - 8.3.2 Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)
  - 8.4 Sickle Cell Anemia
    - 8.4.1 Overview
    - 8.4.2 Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)
  - 8.5 Down Syndrome
    - 8.5.1 Overview
    - 8.5.2 Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)
  - 8.6 Phenylketonuria
    - 8.6.1 Overview
    - 8.6.2 Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)
  - 8.7 Recurrent Pregnancy Loss
    - 8.7.1 Overview
    - 8.7.2 Recurrent Pregnancy Loss Market Revenue and Forecast to 2027 (US$ Mn)
  - 8.8 Antiphospholipid Syndrome (APS)
    - 8.8.1 Overview
    - 8.8.2 Antiphospholipid Syndrome Market Revenue and Forecast to 2027 (US$ Mn)
  - 8.9 Other Diseases
    - 8.9.1 Overview
    - 8.9.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)
  9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Technology
  - 9.1 Overview
  - 9.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Technology 2018 & 2027 (%)
  - 9.4 Spectrophotometer
    - 9.4.1 Overview
    - 9.4.2 Asia Pacific Spectrophotometer Market Revenue and Forecasts to 2027 (US$ Mn)
  - 9.5 Polymerase Chain Reaction Market
    - 9.5.1 Overview
    - 9.5.2 Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)
  - 9.6 Fluorescence in-situ Hybridization Market
    - 9.6.1 Overview
    - 9.6.2 Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
  - 9.7 Array Comparative Genomic Hybridization Market
    - 9.7.1 Overview
    - 9.7.2 Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
  - 9.8 Others Market
    - 9.8.1 Overview
    - 9.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
  10. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User
  - 10.1 Overview
  - 10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by End User 2018 & 2027 (%)
  - 10.3 Hospitals & Clinics
    - 10.3.1 Overview
    - 10.3.2 Asia Pacific Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
  - 10.4 Diagnostics Centers
    - 10.4.1 Overview
    - 10.4.2 Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)
  - 10.5 Other End Users
    - 10.5.1 Overview
    - 10.5.2 Asia Pacific Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
  11. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 - Geographical Analysis
  - 11.1 Asia Pacific Prenatal And Newborn Genetic Testing Market
    - 11.1.1 Overview
    - 11.1.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    - 11.1.3 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.1.3.1 Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.1.3.2 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    - 11.1.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
    - 11.1.5 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
    - 11.1.6 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  - 11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
    - 11.2.1 China Prenatal And Newborn Genetic Testing Market
      - 11.2.1.1 China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.1.2 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.1.2.1 China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.1.2.2 China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.1.3 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.1.4 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.1.5 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.2 Japan Prenatal And New born Genetic Testing Market
      - 11.2.2.1 Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.2.2 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.2.2.1 Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.2.2.2 Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.2.3 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.2.4 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.2.5 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.3 India Prenatal And New born Genetic Testing Market
      - 11.2.3.1 India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.3.2 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.3.2.1 India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.3.2.2 India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.3.3 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.3.4 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.3.5 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.4 Pakistan Prenatal And New born Genetic Testing Market
      - 11.2.4.1 Pakistan Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.4.2 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.4.2.1 Pakistan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.4.2.2 Pakistan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.4.3 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.4.4 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.4.5 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.5 Sri Lanka Prenatal And New born Genetic Testing Market
      - 11.2.5.1 Sri Lanka Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.5.2 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.5.2.1 Sri Lanka Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.5.2.2 Sri Lanka Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.5.3 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.5.4 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.5.5 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.6 Bangladesh Prenatal And New born Genetic Testing Market
      - 11.2.6.1 Bangladesh Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.6.2 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.6.2.1 Bangladesh Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.6.2.2 Bangladesh Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.6.3 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.6.4 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.6.5 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.7 Nepal Prenatal And New born Genetic Testing Market
      - 11.2.7.1 Nepal Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.7.2 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.7.2.1 Nepal Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.7.2.2 Nepal Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.7.3 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.7.4 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.7.5 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.8 Indonesia Prenatal And Newborn Genetic Testing Market
      - 11.2.8.1 Indonesia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.8.2 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.8.2.1 Indonesia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.8.2.2 Indonesia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.8.3 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.8.4 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.8.5 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.9 Singapore Prenatal And Newborn Genetic Testing Market
      - 11.2.9.1 Singapore Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.9.2 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.9.2.1 Singapore Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.9.2.2 Singapore Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.9.3 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.9.4 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.9.5 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.10 Malaysia Prenatal And Newborn Genetic Testing Market
      - 11.2.10.1 Malaysia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.10.2 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.10.2.1 Malaysia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.10.2.2 Malaysia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.10.3 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.10.4 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.10.5 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    - 11.2.11 Thailand Prenatal And Newborn Genetic Testing Market
      - 11.2.11.1 Thailand Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      - 11.2.11.2 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      - 11.2.11.2.1 Thailand Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.11.2.2 Thailand Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      - 11.2.11.3 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      - 11.2.11.4 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
      - 11.2.11.5 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    12. Prenatal And Newborn Genetic Testing Market - Industry Landscape
    - 12.1 Overview
    - 12.2 Comparative Company Analysis
    - 12.3 Growth Strategies Done by the Companies in the Market, (%)
    - 12.4 Organic Developments
      - 12.4.1 Overview
    - 12.5 Inorganic Developments
      - 12.5.1 Overview
    13. Prenatal And Newborn Genetic Testing Market-Key Company Profiles
    - 13.1 LifeCell
      - 13.1.1 Key Facts
      - 13.1.2 Business Description
      - 13.1.3 Financial Overview
      - 13.1.4 Product Portfolio
      - 13.1.5 SWOT Analysis
      - 13.1.6 Key Developments
    - 13.2 Quest Diagnostics Incorporated
      - 13.2.1 Key Facts
      - 13.2.2 Business Description
      - 13.2.3 Financial Overview
      - 13.2.4 Product Portfolio
      - 13.2.5 SWOT Analysis
      - 13.2.6 Key Developments
    - 13.3 Medgenome
      - 13.3.1 Key Facts
      - 13.3.2 Business Description
      - 13.3.3 Financial Overview
      - 13.3.4 Product Portfolio
      - 13.3.5 SWOT Analysis
      - 13.3.6 Key Developments
    - 13.4 Eurofins Scientific
      - 13.4.1 Key Facts
      - 13.4.2 Business Description
      - 13.4.3 Financial Overview
      - 13.4.4 Product Portfolio
      - 13.4.5 SWOT Analysis
      - 13.4.6 Key Developments
    - 13.5 Metropolis India
      - 13.5.1 Key Facts
      - 13.5.2 Business Description
      - 13.5.3 Financial Overview
      - 13.5.4 Product Portfolio
      - 13.5.5 SWOT Analysis
      - 13.5.6 Key Developments
    - 13.6 SRL Diagnostics
      - 13.6.1 Key Facts
      - 13.6.2 Business Description
      - 13.6.3 Financial Information
      - 13.6.4 Product Portfolio
      - 13.6.5 SWOT Analysis
      - 13.6.6 Key Developments
    - 13.7 Sandor Lifesciences Pvt. Ltd.
      - 13.7.1 Key Facts
      - 13.7.2 Business Description
      - 13.7.3 Financial Overview
      - 13.7.4 Product Portfolio
      - 13.7.5 SWOT Analysis
      - 13.7.6 Key Developments
    - 13.8 PerkinElmer, Inc.
      - 13.8.1 Key Facts
      - 13.8.2 Business Description
      - 13.8.3 Financial Overview
      - 13.8.4 Product Portfolio
      - 13.8.5 SWOT Analysis
      - 13.8.6 Key Developments
    - 13.9 Natera, Inc.
      - 13.9.1 Key Facts
      - 13.9.2 Business Description
      - 13.9.3 Financial Overview
      - 13.9.4 Product Portfolio
      - 13.9.5 SWOT Analysis
      - 13.9.6 Key Developments
    - 13.10 Laboratory Corporation Of America Holdings (Sequenom)
      - 13.10.1 Key Facts
      - 13.10.2 Business Description
      - 13.10.3 Financial Overview
      - 13.10.4 Product Portfolio
      - 13.10.5 SWOT Analysis
      - 13.10.6 Key Developments
    - 13.11 Genes2Me LLP
      - 13.11.1 Key Facts
      - 13.11.2 Business Description
      - 13.11.3 Financial Overview
      - 13.11.4 Product Portfolio
      - 13.11.5 SWOT Analysis
      - 13.11.6 Key Developments
    - 13.12 Illumina, Inc.
      - 13.12.1 Key Facts
      - 13.12.2 Business Description
      - 13.12.3 Financial Overview
      - 13.12.4 Product Portfolio
      - 13.12.5 SWOT Analysis
      - 13.12.6 Key Developments
    14. Appendix
    - 14.1 About The Insight Partners
    - 14.2 Glossary Of Terms
    L

Asia Pacific Restorative Dentistry Market Report

Asia Pacific Analog-to-Digital Converter Market Report

Summary:
Get latest Market Research Reports on Asia Pacific Prenatal and Newborn Genetic Testing. Industry analysis & Market Report on Asia Pacific Prenatal and Newborn Genetic Testing is a syndicated market report, published as Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Type (Diagnostic, and Screening), Disease Indication (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, Recurrent Pregnancy Loss, Antiphospholipid Syndrome (APL), and Other Diseases), Technology (Spectrophotometer, Polymerase Chain Reaction, Fluorescence In-situ Hybridization, Array Comparative Genomic Hybridization, and Others), End User (Hospitals & Clinics, Diagnostic Cent. It is complete Research Study and Industry Analysis of Asia Pacific Prenatal and Newborn Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 06 September, 2019

1-User License	$3,000.00
1-5 User License	$4,000.00
Enterprise License	$5,000.00

1-User License	2,397.00
1-5 User License	3,196.00
Enterprise License	3,995.00

1-User License	2,895.00
1-5 User License	3,860.00
Enterprise License	4,825.00

1-User License	471,690.00
1-5 User License	628,920.00
Enterprise License	786,150.00

1-User License	257,130.00
1-5 User License	342,840.00
Enterprise License	428,550.00

Report Detail

Request for Sample of this report

Request for Sample of this report

Table Of Content

TABLE OF CONTENTS

1. Introduction

2. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Takeaways

3. Research Methodology

4. Asia Pacific Prenatal And Newborn Genetic Testing- Market Landscape

5. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Industry Dynamics

6. Prenatal And Newborn Genetic Testing Market - Asia Pacific Analysis

7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Type

8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Disease Indication

9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Technology

10. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User

11. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 - Geographical Analysis

12. Prenatal And Newborn Genetic Testing Market - Industry Landscape

13. Prenatal And Newborn Genetic Testing Market-Key Company Profiles

14. Appendix

L

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter